BUE Equity Snapshot

AZN Weekly Equity Report

AstraZeneca PLC

Latest Close 66,925 ARS 12 Jun 2026
1W Return -4.6% latest completed week
4W Return -0.6% short-term follow-through
12W Return -0.9% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
Company Brief

What the company does

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and …

Snapshot

What the weekly tape is saying

AZN closed the latest completed week at 66,925 ARS. The 4-week return is -0.6% and the 12-week return is -0.9%. Trend Signal is inactive, Market Dynamics is -0.94. Setup signature: Risk-first tape with a 33/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -5.7%
Volume 0.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 43 Persistence of active Trend Signal over the last year and current streak.
Momentum 48 Blend of 4-week and 12-week follow-through.
Dynamics 34 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 20 Participation compared with the 13-week volume baseline.
Risk Control 51 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
70,976 ARS
Vs Trend Line
-5.7%
Fair Value
37,425 ARS
Vs Fair Value
78.8%
52W High
79,799 ARS
52W Low
38,200 ARS
Drawdown
-16.1%
Range Position
69.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -4.6%
4W -0.6%
12W -0.9%
26W -1.4%
52W 50.8%

Trend read

Active Streak
0 weeks
52W Active Weeks
41
52W Active Breadth
78.8%
Sector Scope
AR Healthcare
Sector Rank
19 of 20
Sector Percentile
5.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.94
4W MD Change
11.1%
Relative Strength
-20.06
4W RS Change
-4694.5%
Expectation
Undecided
Probability
48.21%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
753
13W Average
1.6K
52W Average
2.1K
Vs 13W
0.5x
Vs 52W
0.4x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.5%
52W Volatility
4.8%
Upside Weeks
29
Downside Weeks
23
Downside Breadth
44.2%
Avg Gain / Loss
4.1% / -3.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
ARS
Market Cap
104178.2B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 66,925 ARS -4.6% 70,976 ARS 37,425 ARS -0.94 -20.06 753 Off
5 Jun 2026 70,125 ARS 1.9% 70,956 ARS 36,997 ARS -0.94 -9.02 3.6K Off
29 May 2026 68,850 ARS -1.4% 70,701 ARS 36,549 ARS -0.98 -12.81 2.9K Off
22 May 2026 69,825 ARS 3.7% 70,469 ARS 36,109 ARS -1.02 -1.44 4.3K Off
15 May 2026 67,325 ARS -0.6% 70,316 ARS 35,663 ARS -1.06 0.44 549 Off
8 May 2026 67,750 ARS -3.9% 70,250 ARS 35,232 ARS -0.89 -0.59 789 On
1 May 2026 70,525 ARS -0.5% 70,091 ARS 34,800 ARS -0.72 1.63 519 On
24 Apr 2026 70,875 ARS -5.5% 69,901 ARS 34,349 ARS -0.64 2.22 664 On
17 Apr 2026 74,975 ARS -0.6% 69,345 ARS 33,896 ARS -0.61 6.84 2.3K On
10 Apr 2026 75,425 ARS 1.1% 68,827 ARS 33,417 ARS -0.77 4.20 1.3K On
3 Apr 2026 74,600 ARS 7.0% 68,270 ARS 32,935 ARS -0.88 3.50 507 On
27 Mar 2026 69,725 ARS 3.3% 67,677 ARS 32,458 ARS -0.83 4.12 2.0K On
20 Mar 2026 67,500 ARS -3.6% 67,153 ARS 32,012 ARS -0.54 3.72 730 On
13 Mar 2026 70,000 ARS -2.9% 66,696 ARS 31,581 ARS -0.28 11.36 797 On